登录

Raycome Raises ¥55M in Funding Round Led by OFC

作者: Mailman 2021-01-26 16:48
瑞光康泰
http://www.raycome.net
企业数据由 动脉橙 提供支持
医疗器械研发生产商、销售商及慢病管理服务商 | B+轮 | 运营中
中国-广东
2021-01-23
融资金额:RMB¥5500万
东方富海
查看

(VCBeat) Jan. 23, 2021-- Shenzhen Raycome Health Technology Co., Ltd. ("Raycome") closing an investment round of¥55M led by Oriental Fortune Capital (OFC) with participation from Gree Financial Investment, a subsidiary of Gree Group. 


In 2021, Raycome will build an automated production base in Zhuhai with an overall planning area of more than 30,000 square meters for production, experiment, testing, quality control, warehousing and logistics, etc. The new base will use automated production technology to improve productivity, upgrade supply chain in manufacturing, Thus, with the improvements in product quality, cost control and production efficiency, which provide strong support for the new business model of pulse-wave sphygmomanometers, Raycome can greatly promote the process of market expansion, and strengthen its absolute dominant position in the market share.


Raycome is a national high-tech company committed to the overall solutions of hardware and software related to blood pressure (BP). Its fourth generation of double-tube and double-sensor BP accurate measurement technology -- the pulse-wave BP measurement method self-developed by Raycome has applied for invention patents in more than 40 countries around the world and has been granted patents in 9 countries and regions.


Through the pulse-wave sphygmomanometer based on big data, mobile medical treatment and AI technology, Raycome is committed to developing blood pressure management system to provide comprehensive services such as self-service BP measurement, ambulatory BP monitoring, blood pressure monitoring data statistics and analysis at home, health alert, healthy life guidance, and so on. 


>>>>
About Oriental Fortune Capital (OFC)


Founded in 2006, OFC manages 42 funds with AUM of more than 20 billion yuan. OFC invests in small and medium-sized growth-oriented companies. Its funds cover five industries: Telecommunication, Media & Technology (TMT), Green Technology, New Material & Advanced Manufacturing Technology, Healthcare, and Entertainment & Consumption. The company invests in various business development stages through the angel, venture capital, and private equity investment vehicles.


>>>>
About Gree Financial Investment


Gree Financial Investment is an industrial investment company under the management of Gree Group. Located in the Guangdong-Hong Kong-Macao Greater Bay Area, Gree Financial Investment is committed to building itself into a professional, efficient and influential state-owned industrial investment platform based on the development strategy of Zhuhai. 

相关赛道 药械流通
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

Borayer Raises ¥100 million in Extended Series B Round

Hailai Closes ¥500 Million Series C Financing

NowYon Medical Scores ¥100M in Series A and A+ Round of Financing

【首发】神经介入器械公司暖阳医疗完成近亿元A轮及A+轮融资【神经介入专题】

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Aikangte Snags ¥100M in Seris Pre-B Financing

2021-01-26
下一篇

Westlake Therapeutics Secures ¥100 Million in Series Pre-A+ Funding

2021-01-26